desipramine has been researched along with Dyskinesia, Drug-Induced in 7 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chotibut, T | 1 |
| Fields, V | 1 |
| Salvatore, MF | 1 |
| Sagarduy, A | 1 |
| Llorente, J | 1 |
| Miguelez, C | 1 |
| Morera-Herreras, T | 1 |
| Ruiz-Ortega, JA | 1 |
| Ugedo, L | 1 |
| Dupre, KB | 1 |
| Eskow, KL | 1 |
| Barnum, CJ | 2 |
| Bishop, C | 2 |
| Bhide, N | 1 |
| Lindenbach, D | 1 |
| Surrena, MA | 1 |
| Goldenberg, AA | 1 |
| Tignor, S | 1 |
| Klioueva, A | 1 |
| Walters, H | 1 |
| Fulceri, F | 1 |
| Biagioni, F | 1 |
| Ferrucci, M | 1 |
| Lazzeri, G | 1 |
| Bartalucci, A | 1 |
| Galli, V | 1 |
| Ruggieri, S | 1 |
| Paparelli, A | 1 |
| Fornai, F | 1 |
| Saltz, BL | 1 |
| el-Awar, M | 1 |
| Freedman, M | 1 |
| Seeman, P | 1 |
| Goldenberg, L | 1 |
| Little, J | 1 |
| Solomon, P | 1 |
7 other studies available for desipramine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Norepinephrine transporter inhibition with desipramine exacerbates L-DOPA-induced dyskinesia: role for synaptic dopamine regulation in denervated nigrostriatal terminals.
Topics: Animals; Corpus Striatum; Denervation; Desipramine; Dopamine; Dyskinesia, Drug-Induced; Extracellula | 2014 |
Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors.
Topics: Action Potentials; Adrenergic Agents; Adrenergic Uptake Inhibitors; Animals; Buspirone; Desipramine; | 2016 |
Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Agents; Animals; Benzazepines; Biogenic Monoamine | 2008 |
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Neurons; Animals; Behavior, An | 2012 |
Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons.
Topics: Adrenergic Uptake Inhibitors; Animals; Cell Death; Desipramine; Disease Models, Animal; Dopamine; Do | 2007 |
Tardive dyskinesia in the elderly patient.
Topics: Aged; Chlorpromazine; Chronic Disease; Clonazepam; Clozapine; Depressive Disorder; Desipramine; Diph | 1992 |
Response of tardive and L-dopa-induced dyskinesias to antidepressants.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Desipramine; Dyskinesia, Drug-Induced; Humans; Lev | 1987 |